References
- Burstein M. Sur l'effect antagoniste de l'héparine au cours de la deuxième phase de la coagulation. Semaine d. hôp. Paris 1954; 30: 3051
- Burstein M., Guinand A. Sur le temps de thrombine du plasma héparine. Rev. d'hémat 1955; 10: 567
- Edsall J. T., Lever W. F. Effects of ions and neutral molecules on fibrin clotting. J. Biol. Chem 1951; 191: 735
- Fantl P., Marr A.G. M. Phenols as inhibitors of the heparin co-factor of plasma. Nature 1957; 180: 990
- Ferry J. D., Morrison P. R. Preparation and properties of serum and plasma proteins. VIII. The conversion of human fibrinogen to fibrin under various conditions. J. Am. Chem. Soc 1947; 69: 388
- Fischer A. Die Bindung von Heparin an Eiweiss. Biochem. Ztschr 1935; 273: 133
- Godal H. C. Precipitation of human fibrinogen with heparin. Scandinav. J. Clia & Lab. Investigation 1960a; 12: 56
- Godal H. C. The interaction of protamine with human fibrinogen and the significance of this interaction for the coagulation of fibrinogen. Ibid 1960b; 12: 433
- Godal H. C. The assay of heparin in thrombin systems. Ibid 1961, in press
- Gorter E., Nanninga L. Complexes of heparin and proteins. Faraday Soc. Disc 1953; no. 13: p. 205
- Losner S., Volk B. W. Fibrinogen preservation in serum after heparin. Proc. Soc. Exper. Biol. & Med 1954; 54: 417
- Lyttleton J. M. The antithrombin activity of heparin. Biochem. J 1954; 58: 15
- Markwardt F., Walzmann P. Untersuchungen über den Mechanismus der Antithrombinwirkung des Heparins. Ztschr. f. physiol. Chem 1959; 317: 64
- Shinowara G. Y. Enzyme studies on human blood. IV. Interrelation of heparin and fibrinogen fractions. Am. J. Physiol 1949; 156: 458
- Tarlow I. M., Goldfarb A. J., Benjamin B. A method for measuring the tensible strength and stretch of plasma clots. J. Lab. & Clin, Med. 1942; 27: 1333
- Wagreich H., Tarlow J. M. Studies on the strength of fibrinogen thrombin clots. Arch. Biochem. 1945; 7: 345